These mainly include angiogenesis via inhibition of the tyrosine kinase (TKIs) of the Vascular Endothelial Growth Factor Receptor (VEGFR) and an anti-tumor immune response by blocking interactions, which result in the suppression of immune response against the tumor [4]. The gene discussed is KDR; the disease is neoplasm.